Open Access

Upper abdominal body shape is the risk factor for postoperative pancreatic fistula after splenectomy for advanced gastric cancer: A retrospective study

  • Naoto Yamamoto1Email author,
  • Takashi Oshima1,
  • Tsutomu Sato1,
  • Hirochika Makino1,
  • Yasuhiko Nagano1,
  • Shoichi Fujii1,
  • Yasushi Rino2,
  • Toshio Imada2 and
  • Chikara Kunisaki1
World Journal of Surgical Oncology20086:109

DOI: 10.1186/1477-7819-6-109

Received: 22 February 2008

Accepted: 10 October 2008

Published: 10 October 2008

Abstract

Background

Postoperative pancreas fistula (POPF) is a major complication after total gastrectomy with splenectomy. We retrospectively studied the effects of upper abdominal shape on the development of POPF after gastrectomy.

Methods

Fifty patients who underwent total gastrectomy with splenectomy were studied. The maximum vertical distance measured by computed tomography (CT) between the anterior abdominal skin and the back skin (U-APD) and the maximum horizontal distance of a plane at a right angle to U-APD (U-TD) were measured at the umbilicus. The distance between the anterior abdominal skin and the root of the celiac artery (CAD) and the distance of a horizontal plane at a right angle to CAD (CATD) were measured at the root of the celiac artery. The CA depth ratio (CAD/CATD) was calculated.

Results

POPF occurred in 7 patients (14.0%) and was associated with a higher BMI, longer CAD, and higher CA depth ratio. However, CATD, U-APD, and U-TD did not differ significantly between patients with and those without POPF. Logistic-regression analysis revealed that a high BMI (≥25) and a high CA depth ratio (≥0.370) independently predicted the occurrence of POPF (odds ratio = 19.007, p = 0.002; odds ratio = 13.656, p = 0.038, respectively).

Conclusion

Surgical procedures such as total gastrectomy with splenectomy should be very carefully executed in obese patients or patients with a deep abdominal cavity to decrease the risk of postoperative pancreatic fistula. BMI and body shape can predict the risk of POPF simply by CT.

Background

Gastrectomy with D2 lymph node dissection is an established procedure for the treatment of gastric cancer in Japan [13]. Japanese retrospective studies have shown that 20%–30% of patients with advanced cancer of the proximal stomach have nodal metastasis at the splenic hilum. Gastrectomy with dissection for these nodes can yield a 5-year survival of 20%–25%[4].

The most frequent major complication after total gastrectomy with extended dissection is pancreatic fistula [3, 57]. European clinical trials have shown that pancreatic complications are a major cause of mortality after gastrectomy [8, 9]. Moreover, postoperative pancreatic complications are difficult to treat and prolong hospitalization.

Total gastrectomy is a challenging procedure, even for experienced, skilled surgeons because deep sites around the esophageal hiatus or esophagojejunal anastomosis have to be dissected. The depth of the surgical sites is thought to correlate with the difficulty of total gastrectomy, but only a few studies have examined related factors [1012].

This study was designed to evaluate the effects of abdominal shape at the umbilicus and the upper abdomen on short-term surgical outcomes, particularly the incidence of postoperative pancreas fistula (POPF) in patients undergoing total gastrectomy with splenectomy.

Methods

Patients

We retrospectively studied 50 consecutive patients with advanced cancer arising in the upper third of the stomach who underwent D2 or more extensive total gastrectomy with splenectomy between January 2004 and August 2006 at the Department of Surgery, Gastroenterological Center, Yokohama City University. All of the subjects were preoperatively confirmed to have gastric adenocarcinoma on histological examination of endoscopic biopsy specimens. The preoperative evaluation included a barium-swallow examination, an endoscopic examination with biopsy, and computed tomography (CT) in all patients. Abdominal and endoscopic ultrasonography were optional. Staging and lymph node dissection were performed as recommended by the Japanese Research Society for Gastric Cancer [13].

Quantification of abdominal shape

All CT were obtained with patients in a supine position, using a helical CT scanner within 2 months before gastrectomy. The distance between the anterior abdominal skin and the root of celiac artery was defined as CAD. The distance of a horizontal plane at a right angle to CAD was defined as CATD. CAD and CATD were measured on CT at the level of the root of the celiac artery (Figure. 1a). We then calculated the CA depth ratio (CAD/CATD) to more morphologically describe body shape. The maximum vertical distance between the anterior abdominal skin and the back skin was defined as U-APD. The maximum horizontal distance of a plane at a right angle to U-APD was defined as U-TD. U-APD and U-TD were measured on CT scans at the level of the umbilicus (Figure. 1b).
Figure 1

Measurement of body shape. Figures 1a and 1b represent the same patient's images who suffered POPF: a 73-year-old male (gastric cancer), 165 cm, 73 kg, BMI 26.8 kg/m2, CAD 13.1 cm, CATD 32.2 cm, CA-depth ratio 0.407, U-APD 20.0 cm, U-TD 29.0 cm.

Median U-APD, U-TD, CAD, CATD, and CA depth ratio were 19.0 cm (range 13.0–24.0), 29.0 cm (range 21.0–35.0), 10.1 cm (range 5.9–14.2), 29.5 cm (range 23.5–34.2), and 0.370 (range 0.218–0.473), respectively.

Surgical Technique

After transection of the proximal side of the specimen (usually at the abdominal esophagus), the spleen and pancreatic tail is removed from the retroperitoneum. The lymph nodes along the splenic artery are removed, taking particular care to avoid injuring the pancreas. The splenic artery is divided at the end of the pancreatic parenchyma. The splenic vein is ligated and resected at the same level as the splenic artery. After removing the surgical specimen (including the stomach, greater and lesser omenta, and lymph nodes), the correct extent of the retroperitoneal dissection can be fully assessed. Reconstruction was routinely done using a Roux-en-Y technique with a stapler after total gastrectomy; a 25-mm circular stapler was usually used. All patients received antibiotic prophylaxis for the same period. Two or more closed-type drains are routinely applied in the left subphrenic space and around the stump of duodenum in all patients. Drains are removed after the 7th post operative day if there isn't the incidence of intraabdominal complication such as anastomotic leakage or POPF. In case of having intraabdominal infectious complication, we changed drains under radiographic examination and lavaged the cavity through the drains once or twice a day.

Definition of Postoperative Pancreatic Fistula (POPF)

A case of POPF had to satisfy the criteria for the postoperative pancreatic fistula after pancreaticoduodenectomy: Output via an operatively placed drain of any measurable volume of drain fluid on or after postoperative day 3, with amylase content greater than 3 times the upper normal serum level [14].

Statistical Analysis

We reviewed the patients' medical charts and surgical records to obtain the following information: sex (female or male), body mass index (BMI), age (years, <60 or ≥60), operation time (minutes, <300 or ≥300), and volume of bleeding (ml, <500/≥500, <1000/≥1000). Variables of body shape were classified as follows: BMI (kg/m2, <25, or ≥25)[15], U-APD (cm, <19 or ≥19), U-TD (cm, <29 or ≥29), CAD (cm, <10 or ≥10), CATD (cm, <29 or ≥29), and CA depth ratio (<0.370 or ≥0.370). Variables of body shape except for BMI were divided into two groups by median because biologically meaningful cutoff points could not be defined. Preoperative hemoglobin and albumin levels are expressed as means ± SD and were analyzed with Student's t-test. Frequencies were analyzed using the χ2 test or Fisher's exact test. Two-sided p values of less than 0.05 were considered to indicate statistical significance. All of the factors that were significant in the univariate analysis were included in the logistic regression analysis. All analyses were performed using the SPSS program version 11.0.1J for Windows (SPSS Inc., Chicago, IL). This study was approved by our institutional review board.

Results

Clinicopathological characteristics of patients

Pancreatic fistula was diagnosed in 7 of the 50 patients (14.0%). There was no postoperative death due to pancreatic fistula within 30 days or during the hospital stay. The median age of the patients was 66 years (range 39–82 years), and there were 42 (84%) men and 8 (16%) women (Table 1). All patients underwent total gastrectomy and pancreas-preserving splenectomy with D2 or more extended lymph node dissection. The mean operation time was 346 min (range 197–640). There was no difference between the patients with POPF and those without POPF with respect to gender, age, preoperative serum albumin level, hemoglobin level, operation time, or the volume of bleeding (Table 1).
Table 1

Comparison of clinicopathologic characteristics according to the presence or absence of postoperative pancreatic fistula

 

POPF(-)

POPF(+)

P value

Gender, Female/male

8/35

0/7

0.579

Age (yr), <60/≥60

20/23

2/5

0.444

Albumin (g/dl)

3.9 ± 0.5

3.9 ± 0.5

0.794

Hemoglobin (g/dl)

12.7 ± 1.8

13.0 ± 2.7

0.369

Operation time (min), <300/≥300

16/27

3/4

>0.999

Volume of bleeding (ml), <500/≥500, <1000/≥1000

24/14/5

3/2/2

0.484

Incidence of POPF according to the surgeons' experience

Three different surgeons operated on patients within the study group. According to the numbers of previous gastrectomy combined with splenectomy performed by each surgeon (<20 cases vs. ≥20 cases), the surgeons' experience was unrelated to the incidence of POPF; POPF occurred in 4 of 27 patients who underwent gastrectomy by one inexperienced surgeons (<20 cases) and in 3 of 23 patients who underwent gastrectomy by two experienced surgeons (≥20 cases) (P > 0.9999).

Correlation of abdominal shape and body mass index with POPF

Body shape significantly differed between patients with POPF and those without POPF. POPF was significantly associated with a higher BMI, longer CAD, and higher CA depth ratio. However, the presence of POPF was unrelated to CATD, U-APD, and U-TD (Table 2).
Table 2

Comparison of BMI and body shape according to the presence or absence of postoperative pancreatic fistula

 

POPF(-)

POPF(+)

P value

Body mass index (kg/m2), <25/≥25

39/4

3/4

0.009

CAD (cm), <10/≥10

25/18

1/6

0.045

CATD (cm), <29/≥29

23/20

2/5

0.417

U-APD (cm), <19/≥19

23/20

2/5

0.417

U-TD (cm), <29/≥29

29/14

3/4

0.234

CA depth ratio, <0.370/≥0.370

36/7

2/5

0.006

Logistic-regression analysis for the prediction of POPF

The three factors (BMI, CAD, and CA depth ratio) that were significantly associated with POPF in the univariate analysis were entered into a logistic-regression analysis. BMI and CA depth ratio were found to independently predict the occurrence of POPF (Table 3).
Table 3

Predictive factors for POPF as assessed by logistic-regression analysis

 

Odds ratio (95% Confidence Interval)

P value

Body mass index (kg/m2), <25/≥25

19.0 (2.8 – 127.0)

0.002

CA depth ratio, <0.370/≥0.370

13.7 (1.2 – 161.7)

0.038

Discussion

Our study showed that a high BMI and larger upper abdomen independently influenced the risk of POPF in patients undergoing total gastrectomy with splenectomy for advanced gastric cancer. Previously in Japan, pancreaticosplenectomy had been routinely performed to dissect the lymph nodes along the splenic artery and around the splenic hilum in patients with gastric cancer in the upper third of the stomach [16]. However, many centers have recently reported the benefits of pancreas-preserving splenectomy [1720]. Pancreas-preserving total gastrectomy with splenectomy was reported to be superior to total gastrectomy with pancreaticosplenectomy with respect to mortality, morbidity, and 5-year survival rate [4, 8, 21]. Although POPF developed in 49.7% of the patients who underwent total gastrectomy with pancreaticosplenectomy at our hospital, the present study showed that the incidence of POPF has decreased to 14.0% since the introduction of total gastrectomy with pancreas-preserving splenectomy in 2003 [22]. Although modifications of the surgical procedure and improved perioperative management have contributed to decreased morbidity and mortality, POPF remains a severe complication after total gastrectomy [5, 23].

Obesity is a growing problem in developed countries and substantially increases the risks of morbidity and mortality associated with abdominal surgery [2427]. BMI is considered a predictor of surgical outcomes in patients with different types of cancer, including colonic, breast, and endometrial malignancies [2831]. Kodera et al reported that obesity increase the risk of surgical complications in patients who undergo distal gastrectomy with D2 lymphadenectomy [32]. Our study showed that a high BMI influences the risk of postoperative pancreas-related complications. This finding is consistent with the results of a previous study showing that being overweight increases the risk of surgical complications, including pancreatic fistula, in patients who undergo D2 dissection for gastric cancer [26].

Abdominal shape may also influence accessibility in patients with gastric cancer. Total gastrectomy with splenectomy is a more difficult procedure at deeper surgical sites because dissection is required around the esophageal hiatus or esophagojejunal anastomosis. Moreover, a large anterior-to-posterior abdominal wall diameter may make it difficult to dissect along the splenic artery or to mobilize the spleen in deep sites of the abdominal cavity. Lee et al. reported that obesity and abdominal shape at the umbilical level both influence the short-time outcomes of subtotal gastrectomy with D2 lymph node dissection in patients with gastric cancer [33]. In our study, we measured CAD and CATD to quantify upper abdominal shape, unlike previous studies [33]. We believe that a higher CA depth ratio requires a deeper surgical site. We found that upper abdominal shape as represented by CAD or CA depth ratio was related to the incidence of POPF, whereas body shape at the umbilicus was not. Tsukada et al. reported that accumulation of body fat is significantly associated with postoperative complications after elective gastric or colorectal surgery [27]. Seki et al. measured the visceral fat mass by using software to estimate fat volume, and examined the relation to operative time in patients with rectosigmoid cancer. They concluded that the amount of visceral fat was a more useful predictor of operative difficulty than was BMI [34]. Because we did not measure the amount of body fat in our study, the relations among upper abdominal shape, body fat amount, and POPF remain unclear.

Although, age, BMI, serum zinc level, hyperlipidemia, and comorbidity were significantly related to the incidence of POPF after pancreaticosplenectomy for advanced gastric cancer in our previous study [22], none of these factors, except for BMI, was positively associated with the incidence of POPF in this study. In contrast, we found that the shape of the upper abdomen significantly correlated with POPF. One of the reasons for the inconsistent results might be the difference in the operative procedures (pancreaticosplenectomy vs. pancreas-preserving splenectomy).

It is well-known that abdominal adiposity is strongly associated with increased incidence of diabetes mellitus (DM) which may also contribute to post-operative complication [4, 35, 36]. Russo et al. demonstrating that obesity and DM were independent predictors of surgical complication [37]. In our study, there were only 8 of 50 patients with DM. Among these patients, there was no significant difference of the incidence of POPF between the patients with and without DM.

Mathur et al. reported that fatty pancreas is risk of postoperative pancreatic leakage after pancreatoduodenectomy [38]. Kovanlikaya et al reported that there are positively correlated BMI and pancreatic fat content by magnetic resonance imaging [39]. Much visceral fat around pancreas is thought to make it hard to identify a border between pancreatic parenchyma and surrounding tissue. Therefore, there might be the risk for damaging the pancreatic substance without noticing. In our present study, no prospective data are available to correlate the texture of the pancreas. Therefore, future studies should be designed to capture this information and investigate the risk of POPF by analyzing the correlation between body shape, visceral fat around pancreas, and the texture of the pancreas.

It is thought that surgical procedure in a deep abdominal cavity such as left subphrenic space, dissection and ligation need particular skill. We think that it is easy for an experienced surgeon to imagine that the bleeding due to injury of the spleen is caused by immature surgical maneuver. It has been reported about utility of Ligasure™ in an operation of gastric cancer by randomized study [40]. We think that we can manipulate effectively and safety by using new surgical instrument (Ligasure™) in such a deep operation field, and we can perform safe maneuver recently. Therefore, the incidence of POPF might be low.

There are several potential limitations of our study. First, a major limitation of our study was the low-power statistics because of the small number of patients enrolled to this study. At our institution, although most patients with advanced gastric cancer are treated by total gastrectomy with splenectomy, most patients with early gastric cancer in the upper third of the stomach are treated by proximal gastrectomy or total gastrectomy without splenectomy. Hence it is difficult to collect large numbers of patients who underwent total gastrectomy with splenectomy. Splenectomy has been advocated to facilitate dissection of lymph nodes at the splenic hilum and along the splenic artery [4, 41, 42], and total gastrectomy without splenectomy has been performed for early gastric cancer which maneuver around pancreas is omitted by reduced range of lymphadenectomy. Therefore, we reviewed about incidence of a pancreas-related complication after splenectomy. Second, the proportion of patients with high BMI (BMI ≥ 25) in this study was low (16.0%). Therefore, the obtained results are not definitely conclusive, but our results suggest that caution is needed when performing total gastrectomy with splenectomy for gastric cancer in overweight patients. Third, a major limitation of our study was the low-power statistics because of the low incidence of POPF. Although mortality rates from gastrectomy complicated by pancreas-related abscess are lower in Japan than those reported in Western series [8, 9], pancreas related abscess formation remains a strong factor in the mortality and morbidity rates in both Japanese and Western centers. Thus we think a large study will be necessary to obtain a definitive conclusion.

It does not have doubt that BMI is useful when we evaluate difficulty of operation for obese patient. However, in our result, there were not many cases with BMI high level. By contrast, there were some cases having high level of CA depth ratio in spite of low BMI. Therefore, we think it is important to measure upper abdominal body shape.

Conclusion

In conclusion, our results indicate that surgical procedures such as total gastrectomy with splenectomy should be very carefully executed in obese patients or patients with a deep abdominal cavity to decrease the risk of postoperative pancreatic fistula. It is easy to measure the CAD and CATD at the level of the root of celiac artery by preoperative CT, and we can also do it retrospectively. Thus, CAD and CATD should be routinely evaluated in patients who undergo upper abdominal surgery particularly total gastrectomy with splenectomy. A worldwide study will be necessary to obtain a definitive conclusion.

Declarations

Acknowledgements

The authors thank Dr. S. Morita MD. for excellent statistical advices.

Authors’ Affiliations

(1)
Yokohama City University Medical Center, Gastroenterological Surgery
(2)
Yokohama City University

References

  1. Kaminishi M, Shimoyama S, Yamaguchi H, Yamada H, Ogawa T, Kawahara M, Joujima Y, Oohara T: Results of subtotal gastrectomy with complete dissection of the N2 lymph nodes preserving the spleen and pancreas in surgery for gastric cancer. Hepatogastroenterology. 1994, 41: 384-387.PubMedGoogle Scholar
  2. Degiuli M, Sasako M, Ponzetto A, Allone T, Soldati T, Calgaro M, Balcet F, Bussone R, Olivieri F, Scaglione D: Extended lymph node dissection for gastric cancer: results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol. 1997, 23: 310-314. 10.1016/S0748-7983(97)90696-X.View ArticlePubMedGoogle Scholar
  3. Furukawa H, Hiratsuka M, Ishikawa O, Ikeda M, Imamura H, Masutani S, Tatsuta M, Satomi T: Total gastrectomy with dissection of lymph nodes along the splenic artery: a pancreas-preserving method. Ann Surg Oncol. 2000, 7: 669-673. 10.1007/s10434-000-0669-6.View ArticlePubMedGoogle Scholar
  4. Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K: Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg. 1995, 19: 532-536. 10.1007/BF00294714.View ArticlePubMedGoogle Scholar
  5. Sasako M, Katai H, Sano T, Maruyama K: Management of complications after gastrectomy with extended lymphadenectomy. Surg Oncol. 2000, 9: 31-34. 10.1016/S0960-7404(00)00019-0.View ArticlePubMedGoogle Scholar
  6. Kostic Z, Cuk V, Ignjatovic M, Usaj-Knezevic S: [Early complications following radical surgical treatment of patients with gastric adenocarcinoma]. Vojnosanit Pregl. 2006, 63: 249-256.View ArticlePubMedGoogle Scholar
  7. Szucs G, Toth I, Gyani K, Kiss JI: [Effect of extending the resection on postoperative complications of total gastrectomies: experience with 161 operations]. Magy Seb. 2002, 55: 362-368.PubMedGoogle Scholar
  8. Bonenkamp JJ, Songun I, Hermans J, Sasako M, Welvaart K, Plukker JT, van Elk P, Obertop H, Gouma DJ, Taat CW: Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet. 1995, 345: 745-748. 10.1016/S0140-6736(95)90637-1.View ArticlePubMedGoogle Scholar
  9. Cuschieri A, Fayers P, Fielding J, Craven J, Bancewicz J, Joypaul V, Cook P: Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet. 1996, 347: 995-999. 10.1016/S0140-6736(96)90144-0.View ArticlePubMedGoogle Scholar
  10. Roukos DH: Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol. 1999, 6: 46-56. 10.1007/s10434-999-0046-z.View ArticlePubMedGoogle Scholar
  11. Siewert JR, Stein HJ, Sendler A, Fink U: Surgical resection for cancer of the cardia. Semin Surg Oncol. 1999, 17: 125-131. 10.1002/(SICI)1098-2388(199909)17:2<125::AID-SSU7>3.0.CO;2-9.View ArticlePubMedGoogle Scholar
  12. Stein HJ, Feith M, Siewert JR: Cancer of the esophagogastric junction. Surg Oncol. 2000, 9: 35-41. 10.1016/S0960-7404(00)00021-9.View ArticlePubMedGoogle Scholar
  13. Japanese Gastric Cancer Association. Japanese Classification of Gastric Carcinoma: 2nd English Edition. 1998
  14. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M: Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005, 138: 8-13. 10.1016/j.surg.2005.05.001.View ArticlePubMedGoogle Scholar
  15. Seidell JC, Flegal KM: Assessing obesity: classification and epidemiology. Br Med Bull. 1997, 53: 238-252.View ArticlePubMedGoogle Scholar
  16. Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P: Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer. 1999, 79: 1522-1530. 10.1038/sj.bjc.6690243.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Monig SP, Collet PH, Baldus SE, Schmackpfeffer K, Schroder W, Thiele J, Dienes HP, Holscher AH: Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus. J Surg Oncol. 2001, 76: 89-92. 10.1002/1096-9098(200102)76:2<89::AID-JSO1016>3.0.CO;2-I.View ArticlePubMedGoogle Scholar
  18. Liotta G, Federici O: [D2 pancreas-preserving lymphadenectomy in tumors of the upper third of the stomach]. Tumori. 2003, 89: 67-69.PubMedGoogle Scholar
  19. Degiuli M, Sasako M, Ponti A, Calvo F: Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer. 2004, 90: 1727-1732.PubMed CentralPubMedGoogle Scholar
  20. Koufuji K, Shirouzu K, Aoyagi K, Yano S, Miyagi M, Imaizumi T, Takeda J: Surgery and clinicopathological features of gastric adenocarcinoma involving the esophago-gastric junction. Kurume Med J. 2005, 52: 73-79. 10.2739/kurumemedj.52.73.View ArticlePubMedGoogle Scholar
  21. Okajima K, Isozaki H: Splenectomy for treatment of gastric cancer: Japanese experience. World J Surg. 1995, 19: 537-540. 10.1007/BF00294715.View ArticlePubMedGoogle Scholar
  22. Kunisaki C, Shimada H, Ono H, Otsuka Y, Matsuda G, Nomura M, Akiyama H: Predictive factors for pancreatic fistula after pancreaticosplenectomy for advanced gastric cancer in the upper third of the stomach. J Gastrointest Surg. 2006, 10: 132-137. 10.1016/j.gassur.2005.04.015.View ArticlePubMedGoogle Scholar
  23. Ichikawa D, Kurioka H, Yamaguchi T, Koike H, Okamoto K, Otsuji E, Shirono K, Shioaki Y, Ikeda E, Mutoh F, Yamagishi H: Postoperative complications following gastrectomy for gastric cancer during the last decade. Hepatogastroenterology. 2004, 51: 613-617.PubMedGoogle Scholar
  24. Kodera Y, Sasako M, Yamamoto S, Sano T, Nashimoto A, Kurita A: Identification of risk factors for the development of complications following extended and superextended lymphadenectomies for gastric cancer. Br J Surg. 2005, 92: 1103-1109. 10.1002/bjs.4979.View ArticlePubMedGoogle Scholar
  25. Dhar DK, Kubota H, Tachibana M, Kotoh T, Tabara H, Masunaga R, Kohno H, Nagasue N: Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology. 2000, 59: 18-23. 10.1159/000012131.View ArticlePubMedGoogle Scholar
  26. Tsujinaka T, Sasako M, Yamamoto S, Sano T, Kurokawa Y, Nashimoto A, Kurita A, Katai H, Shimizu T, Furukawa H: Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501). Ann Surg Oncol. 2007, 14: 355-361. 10.1245/s10434-006-9209-3.View ArticlePubMedGoogle Scholar
  27. Tsukada K, Miyazaki T, Kato H, Masuda N, Fukuchi M, Fukai Y, Nakajima M, Ishizaki M, Motegi M, Mogi A: Body fat accumulation and postoperative complications after abdominal surgery. Am Surg. 2004, 70: 347-351.PubMedGoogle Scholar
  28. Lee CT, Dunn RL, Chen BT, Joshi DP, Sheffield J, Montie JE: Impact of body mass index on radical cystectomy. J Urol. 2004, 172: 1281-1285. 10.1097/01.ju.0000138785.48347.aa.View ArticlePubMedGoogle Scholar
  29. Leroy J, Ananian P, Rubino F, Claudon B, Mutter D, Marescaux J: The impact of obesity on technical feasibility and postoperative outcomes of laparoscopic left colectomy. Ann Surg. 2005, 241: 69-76.PubMed CentralPubMedGoogle Scholar
  30. Erkanli S, Kayaselcuk F, Bagis T, Kuscu E: Impact of morbid obesity in surgical management of endometrial cancer: surgical morbidity, clinical and pathological aspects. Eur J Gynaecol Oncol. 2006, 27: 401-404.PubMedGoogle Scholar
  31. El-Tamer MB, Ward BM, Schifftner T, Neumayer L, Khuri S, Henderson W: Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. Ann Surg. 2007, 245: 665-671. 10.1097/01.sla.0000245833.48399.9a.PubMed CentralView ArticlePubMedGoogle Scholar
  32. Kodera Y, Ito S, Yamamura Y, Mochizuki Y, Fujiwara M, Hibi K, Ito K, Akiyama S, Nakao A: Obesity and outcome of distal gastrectomy with D2 lymphadenectomy for carcinoma. Hepatogastroenterology. 2004, 51: 1225-1228.PubMedGoogle Scholar
  33. Lee JH, Paik YH, Lee JS, Ryu KW, Kim CG, Park SR, Kim YW, Kook MC, Nam BH, Bae JM: Abdominal shape of gastric cancer patients influences short-term surgical outcomes. Ann Surg Oncol. 2007, 14: 1288-1294. 10.1245/s10434-006-9235-1.View ArticlePubMedGoogle Scholar
  34. Seki Y, Ohue M, Sekimoto M, Takiguchi S, Takemasa I, Ikeda M, Yamamoto H, Monden M: Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index. Surg Endosc. 2007, 21: 929-934. 10.1007/s00464-006-9084-9.View ArticlePubMedGoogle Scholar
  35. Fernandez-Real JM, Vayreda M, Casamitjana R, Saez M, Ricart W: [Body mass index (BMI) and percent fat mass. A BMI > 27.5 kg/m2 could be indicative of obesity in the Spanish population]. Med Clin (Barc). 2001, 117: 681-684.View ArticleGoogle Scholar
  36. Miyatake N, Takanami S, Kawasaki Y, Fujii M: Relationship between visceral fat accumulation and physical fitness in Japanese women. Diabetes Res Clin Pract. 2004, 64: 173-179. 10.1016/j.diabres.2003.11.004.View ArticlePubMedGoogle Scholar
  37. Russo PL, Spelman DW: A new surgical-site infection risk index using risk factors identified by multivariate analysis for patients undergoing coronary artery bypass graft surgery. Infect Control Hosp Epidemiol. 2002, 23: 372-376. 10.1086/502068.View ArticlePubMedGoogle Scholar
  38. Mathur A, Pitt HA, Marine M, Saxena R, Schmidt CM, Howard TJ, Nakeeb A, Zyromski NJ, Lillemoe KD: Fatty pancreas: a factor in postoperative pancreatic fistula. Ann Surg. 2007, 246: 1058-1064.View ArticlePubMedGoogle Scholar
  39. Kovanlikaya A, Mittelman SD, Ward A, Geffner ME, Dorey F, Gilsanz V: Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol. 2005, 35: 601-607. 10.1007/s00247-005-1413-y.View ArticlePubMedGoogle Scholar
  40. Lee WJ, Chen TC, Lai IR, Wang W, Huang MT: Randomized clinical trial of Ligasure versus conventional surgery for extended gastric cancer resection. Br J Surg. 2003, 90: 1493-1496. 10.1002/bjs.4362.View ArticlePubMedGoogle Scholar
  41. Soga J, Kobayashi K, Saito J, Fujimaki M, Muto T: The role of lymphadenectomy in curative surgery for gastric cancer. World J Surg. 1979, 3: 701-708. 10.1007/BF01654793.View ArticlePubMedGoogle Scholar
  42. Wanebo HJ, Kennedy BJ, Winchester DP, Stewart AK, Fremgen AM: Role of splenectomy in gastric cancer surgery: adverse effect of elective splenectomy on longterm survival. J Am Coll Surg. 1997, 185: 177-184.View ArticlePubMedGoogle Scholar

Copyright

© Yamamoto et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement